1. [Aortic stenosis in the elderly: The TAVI revolution]
- Author
-
Pavel, Overtchouk and Jean-Philippe, Collet
- Subjects
Bioprosthesis ,Postoperative Care ,Transcatheter Aortic Valve Replacement ,Postoperative Complications ,Heart Valve Prosthesis ,Humans ,Thrombosis ,Aortic Valve Stenosis ,Risk Assessment ,Platelet Aggregation Inhibitors ,Aged - Abstract
TAVI is currently recommended for severe symptomatic aortic stenosis in patients at prohibitive, high or intermediate surgical risk as estimated by surgical risk scores (STS score and EuroSCORE II). Comorbidity, technical feasibility of TAVI and concurrent pathology with need for complementary surgical correction are conditions to be considered to choose between open surgery and TAVI. The decision is often made by the "Heart Team". The transfemoral access must be favored. Conduction disturbance, stroke, bioprosthesis thrombosis and durability are the main setbacks of TAVI. Double antiplatelet therapy with aspirin and clopidogrel during 3 to 6 months is currently recommended after TAVI, followed by long-term aspirin single therapy.
- Published
- 2018